Valuation: Faes Farma, S.A.

Market Cap 1.48B 1.67B 1.38B 1.25B 2.37B 161B 2.39B 16.63B 6.47B 81.96B 6.26B 6.12B 263B P/E 2026 *
17x
P/E 2027 * 13.5x
Enterprise Value 1.76B 1.99B 1.65B 1.5B 2.83B 192B 2.85B 19.82B 7.71B 97.7B 7.46B 7.3B 314B EV / Sales 2026 *
2.41x
EV / Sales 2027 * 2.18x
Free-Float
78.08%
Yield 2026 *
2.81%
Yield 2027 * 3.47%
1 day+3.04%
1 week+0.53%
Current month+1.82%
1 month+5.20%
3 months+4.17%
6 months+1.17%
Current year-7.95%
1 week 4.52
Extreme 4.52
4.76
1 month 4.42
Extreme 4.415
4.82
Current year 4.32
Extreme 4.315
5.44
1 year 4.32
Extreme 4.315
5.44
3 years 2.86
Extreme 2.865
5.44
5 years 2.86
Extreme 2.865
5.44
10 years 2.57
Extreme 2.57
5.48
Manager TitleAgeSince
Chief Executive Officer - 2024-08-31
Director of Finance/CFO - 2025-07-13
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman - 1991-05-15
Director/Board Member - 2010-08-01
Director/Board Member - 2019-06-18
Date Insider Type Main position Quantity % Market Cap. Importance
2/4/26 Others

Director

53,900 0.0170%
2/4/26 Others

Director

87,383 0.0276%
2/4/26 Sell

Director

24,000 0.0076%
Change 5-day change 1-year change 3-year change Capi.($)
+3.04%+0.53%+9.20%+52.49% 1.61B
+1.26%-2.29%+36.97%+104.79% 1,019B
+0.73%-4.78%+35.41%+61.62% 610B
+0.35%+1.29%+15.86%+79.90% 470B
+1.72%-4.92%+59.84%+36.64% 344B
+0.26%+0.14%+21.29%+40.99% 336B
+0.60%-3.09%+10.76%+32.59% 266B
+1.65%-3.78%-6.03%+9.29% 241B
-0.09%-4.97%+36.88%+50.52% 218B
-0.28%-4.66%+26.99%+92.98% 179B
Average +0.64%-3.29%+24.72%+56.18% 368.44B
Weighted average by Cap. +0.05%-3.43%+29.52%+67.01%

Financials

2026 *2027 *
Net sales 733M 826M 686M 622M 1.17B 79.63B 1.18B 8.24B 3.21B 40.62B 3.1B 3.03B 131B 793M 893M 742M 673M 1.27B 86.11B 1.28B 8.91B 3.47B 43.93B 3.35B 3.28B 141B
Net income 87.37M 98.42M 81.76M 74.11M 140M 9.49B 141M 982M 382M 4.84B 369M 362M 15.56B 111M 125M 104M 94.15M 178M 12.05B 179M 1.25B 485M 6.15B 469M 459M 19.77B
Net Debt 284M 320M 266M 241M 455M 30.87B 459M 3.19B 1.24B 15.75B 1.2B 1.18B 50.62B 248M 280M 232M 211M 398M 26.96B 401M 2.79B 1.09B 13.75B 1.05B 1.03B 44.21B
Projected Income Statement - Annual - Faes Farma, S.A.
Logo Faes Farma, S.A.
Faes Farma SA is a Spain-based company engaged in the pharmaceutical industry. The Company specializes in the research, production, distribution and sale of prescription and generic drugs, over-the-counter (OTC) medicines, food supplements and personal care treatments, as well as raw materials for the pharmaceutical use. The Company’s research lines are mainly focused on the development of new drugs for the treatment of allergy, venous insufficiency and irritable bowel syndrome, among others. In addition, it provides animal nutrition products. The Company operates in Spain, Portugal, Chile and Mexico, among others. It controls a number of subsidiaries, such as Laboratorios Vitoria SA, Laboratorios Veris SA, Lazlo International SA, Ingaso Farm SLU, Esfion SA and Biotecnet I MAS D SA.
Employees
2,611
Date Price Change Volume
26-10-06 €4.750 +3.04% 196,910
26-10-05 €4.610 +1.99% 95,612
26-10-02 €4.520 -0.66% 102,326
26-10-01 €4.550 -2.47% 152,352
26-09-30 €4.665 -1.27% 112,273
Trader
Investor
Global
Quality
ESG MSCI
A
Ratings Surperformance© - Faes Farma, S.A.
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
4
Last Close Price
4.750EUR
Average target price
5.355EUR
Spread / Average Target
+12.74%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Faes Farma, S.A.